JIANGSU HENGRUI PHARMACEUTICALS CO LTD

Overview

JIANGSU HENGRUI PHARMACEUTICALS CO LTD is an active pharmaceutical ingredient (API) supplier with 31 active FDA Type II Drug Master Files, covering 2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-yl) ANILINE; 4-(TRIFLUOROMETHOXY) ANILINE; BUPIVACAINE BASE; CABAZITAXEL; CARFILZOMIB; CARMUSTINE USP NON STERILE BULK DRUG SUBSTANCE.

API / Drug Master Files

JIANGSU HENGRUI PHARMACEUTICALS CO LTD holds 31 active (40 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CABAZITAXELActive2025-12-09
• 2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-yl) ANILINEActive2024-12-06
• ER301 NON-STERILE DRUG SUBSTANCE INTERMEDIATEActive2024-09-20
• CARFILZOMIBActive2023-09-06
• RIVOCERANIB MESYLATE, NON-STERILE, BULK DRUG SUBSTANCEActive2023-01-20
• TENOFOVIRActive2021-05-17
• SHR169106Active2020-08-13
• BUPIVACAINE BASEActive2020-06-29
• GADOBUTROL USPActive2020-05-28
• GADOTERATE MEGLUMINEActive2020-03-31
• SHR0302 NON-STERILE BULK DRUG SUBSTANCEActive2018-08-21
• CARMUSTINE USP NON STERILE BULK DRUG SUBSTANCEActive2017-10-27
• IODIXANOL USPActive2017-01-11
• POSACONAZOLE FORM IActive2016-10-14
• SEVOFLURANE USPActive2016-09-28

Showing 15 of 40 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to JIANGSU HENGRUI PHARMACEUTICALS CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.